Archives

img-01

The Promise of Regenerative Medicine in Asia

This article was also published on MedTech Intelligence. Regenerative medicine focuses on harnessing the body’s ability to heal itself by restoring the functionality of damaged tissues and organs. Current medicine treats symptoms but oftentimes does not repair the underlying problems, which is... Read More

img-01

Asia Increases Efforts to Promote Vaccinations

Multiple countries in the APAC region have been experiencing outbreaks of preventable diseases in 2016.  The number of Singapore’s measles cases doubled in the first half of 2016 compared to the same time period in 2015, while Malaysia’s tripled from 2015 to... Read More

img-01

China Clinical Trials Update

The China Food and Drug Administration (CFDA) has released technical guidance on clinical trials, which outlines the entire clinical trial process for drug developers. The guide provides a comprehensive overview of the drug development process, including fundamental ethical principles and more detailed... Read More

img-01

CFDA Now Accepting Priority Review Applications

Beginning January 1, 2017, the China Food and Drug Administration (CFDA) will be accepting priority review applications for medical devices.  Eligible devices include class III devices manufactured in China and class II and III imported devices.  This final decision follows the CFDA’s... Read More

img-01

Asia Behind in Health Economics

While the US and EU have been using health economics outcomes for drugs and devices for a number of years, Asia is behind in this area.  Much of this is caused by the lack of standardized systems, regulations, and resources needed to... Read More